
Octalfa
AI Verified
France
Venture Capital
Chemin du Saquin, Écully, Lyon, Métropole de Lyon, Rhône, Auvergne-Rhône-Alpes, Metropolitan France, 69130, France
2007
Criteria | Requirements | Match |
---|---|---|
Regions | North America, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Series A, Series B, Growth Stage, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Octalfa stands as a distinguished independent family enterprise with nearly three decades of dedication to innovation in healthcare and life sciences. Founded by Gilles Alberici, the group has established itself as a significant player in biotechnology, focusing on critical medical domains including pediatric medicine, cancer immunology, advanced diagnostics, and specialized materials development. Their entrepreneurial approach combines scientific expertise with strategic investment vision, creating a unique position in the European biotech investment landscape.
The investment portfolio of Octalfa reflects their deep commitment to transformative healthcare solutions. Their capital allocation strategy prioritizes companies developing breakthrough technologies with potential for substantial clinical impact. With investments spanning early-stage startups to more established biotech firms, Octalfa has cultivated a diverse ecosystem of portfolio companies working on next-generation therapeutics, diagnostic platforms, and medical technologies. Their investment approach typically combines financial support with strategic guidance, leveraging the family's extensive industry connections and scientific expertise to accelerate growth.
Beyond pure financial returns, Octalfa demonstrates a profound commitment to social responsibility through the Dominique & Tom Alberici Foundation and their dedicated endowment fund. Since 2008, these philanthropic initiatives have been fully integrated into the group's core strategy and governance structure. Their humanitarian efforts specifically target support for cancer patients and individuals with disabilities, with a special emphasis on pediatric care. These programs operate primarily in France and Madagascar, reflecting the group's international humanitarian vision while maintaining strong regional connections.
What distinguishes Octalfa in the investment landscape is their holistic approach to value creation. Rather than viewing their portfolio companies as mere financial assets, they foster an ecosystem where scientific innovation, business development, and social impact coexist harmoniously. This philosophy has enabled them to maintain long-term partnerships with researchers, healthcare institutions, and fellow investors across Europe. As the biotech sector continues evolving, Octalfa's combination of family-driven values with sophisticated investment strategies positions them uniquely to support the next generation of healthcare innovations while maintaining their commitment to improving patient outcomes worldwide.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Octalfa maintains its global headquarters in France, serving as the strategic center for its operations. The company's primary corporate offices are located at Chemin du Saquin, Écully, Lyon, Métropole de Lyon, Rhône, Auvergne-Rhône-Alpes, Metropolitan France, 69130, France.
Octalfa focuses its investment activities on companies operating in the following stages: Seed, Series A, Series B, Growth Stage, Pre-Seed. Octalfa provides strategic capital and expertise to support promising businesses at these critical phases of development.
Octalfa maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Western Europe.
Octalfa was established in 2007, marking the beginning of its journey as an investment firm.
Octalfa is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.